Innoveren Scientific Inc. (IVRN)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Apr 29, 2025
Innoveren Scientific Statistics
Total Valuation
IVRN has a market cap or net worth of 1,602. The enterprise value is 4.33 million.
Market Cap | 1,602 |
Enterprise Value | 4.33M |
Important Dates
The last earnings date was Friday, May 2, 2025.
Earnings Date | May 2, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
IVRN has 8.01 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 8.01M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | -36.24% |
Owned by Insiders (%) | 8.71% |
Owned by Institutions (%) | n/a |
Float | 7.23M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | -0.00 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.33 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.08
Current Ratio | 0.08 |
Quick Ratio | 0.06 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -4.77 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -253.59% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 23.55% |
Revenue Per Employee | n/a |
Profits Per Employee | -1.63M |
Employee Count | 2 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.00% in the last 52 weeks. The beta is 488.62, so IVRN's price volatility has been higher than the market average.
Beta (5Y) | 488.62 |
52-Week Price Change | -99.00% |
50-Day Moving Average | 0.03 |
200-Day Moving Average | 1.05 |
Relative Strength Index (RSI) | 33.92 |
Average Volume (20 Days) | 37,193 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.14 |
Income Statement
Revenue | n/a |
Gross Profit | -999 |
Operating Income | -2.09M |
Pretax Income | -3.26M |
Net Income | -3.26M |
EBITDA | -2.08M |
EBIT | -2.09M |
Earnings Per Share (EPS) | -5.51 |
Balance Sheet
The company has 543,882 in cash and 4.44 million in debt, giving a net cash position of -3.89 million or -0.49 per share.
Cash & Cash Equivalents | 543,882 |
Total Debt | 4.44M |
Net Cash | -3.89M |
Net Cash Per Share | -0.49 |
Equity (Book Value) | -10.89M |
Book Value Per Share | -15.91 |
Working Capital | -8.91M |
Cash Flow
Operating Cash Flow | -918,105 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
IVRN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -152.30% |
Shareholder Yield | -152.30% |
Earnings Yield | -203,408.43% |
FCF Yield | n/a |
Stock Splits
The last stock split was on June 13, 2022. It was a reverse split with a ratio of 0.001.
Last Split Date | Jun 13, 2022 |
Split Type | Reverse |
Split Ratio | 0.001 |
Scores
IVRN has an Altman Z-Score of -130.59. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -130.59 |
Piotroski F-Score | n/a |